Salivary IL-1β, IL-6, and IL-10 Are Key Biomarkers of Periodontitis Severity.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
01 Aug 2024
Historique:
received: 16 06 2024
revised: 11 07 2024
accepted: 26 07 2024
medline: 10 8 2024
pubmed: 10 8 2024
entrez: 10 8 2024
Statut: epublish

Résumé

To explore severity and progression biomarkers, we examined the clinical relevance of multiple cytokines and mediators involved in the inflammatory response in periodontitis. A cohort of 68 patients was enrolled in the study and periodontal status assessed by the current classification of periodontal diseases. Immune mediators present in saliva, of both patients and healthy controls, were quantified using a Legendplex-13 panel. Clinic parameters were significantly higher in PD patients compared with HC, with a strong significant association with the disease severity (stage) (

Identifiants

pubmed: 39125970
pii: ijms25158401
doi: 10.3390/ijms25158401
pii:
doi:

Substances chimiques

Biomarkers 0
Interleukin-1beta 0
Interleukin-6 0
Interleukin-10 130068-27-8
IL1B protein, human 0
IL6 protein, human 0
IL10 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Cooperativa de Ensino Superior Politécnico e Universitário
ID : AMDNCPD_PI2RL_IINFACTS_2021 and ADMT1PD_GI2-CESPU_2022
Organisme : Fundação para a Ciência e Tecnologia
ID : UIDB/50026/2020 and UIDP/50026/2020

Auteurs

Marta Relvas (M)

University Institute of Health Sciences (IUCS-CESPU), 4585-116 Gandra, Portugal.
Oral Pathology and Rehabilitation Research Unit (UNIPRO), University Institute of Health Sciences (IUCS-CESPU), CRL, 4585-116 Gandra, Portugal.

Ana Mendes-Frias (A)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057 Braga, Portugal.
ICVS/3B's-PT Government Associate Laboratory, 4710-057 Braga, Portugal.

Maria Gonçalves (M)

University Institute of Health Sciences (IUCS-CESPU), 4585-116 Gandra, Portugal.
UCIBIO-Applied Molecular Biosciences Unit, Toxicologic Pathology Research Laboratory, University Institute of Health Sciences (1H-TOXRUN, IUCS-CESPU), 4585-116 Gandra, Portugal.

Filomena Salazar (F)

University Institute of Health Sciences (IUCS-CESPU), 4585-116 Gandra, Portugal.
Oral Pathology and Rehabilitation Research Unit (UNIPRO), University Institute of Health Sciences (IUCS-CESPU), CRL, 4585-116 Gandra, Portugal.

Paula López-Jarana (P)

University Institute of Health Sciences (IUCS-CESPU), 4585-116 Gandra, Portugal.
Oral Pathology and Rehabilitation Research Unit (UNIPRO), University Institute of Health Sciences (IUCS-CESPU), CRL, 4585-116 Gandra, Portugal.

Ricardo Silvestre (R)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057 Braga, Portugal.
ICVS/3B's-PT Government Associate Laboratory, 4710-057 Braga, Portugal.

Alexandra Viana da Costa (A)

University Institute of Health Sciences (IUCS-CESPU), 4585-116 Gandra, Portugal.
UCIBIO-Applied Molecular Biosciences Unit, Toxicologic Pathology Research Laboratory, University Institute of Health Sciences (1H-TOXRUN, IUCS-CESPU), 4585-116 Gandra, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH